Accelerated Pharma (Accelerated Pharma) Price-to-Operating-Cash-Flow : (As of May. 21, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Price-to-Operating-Cash-Flow?

As of today (2024-05-21), Accelerated Pharma's share price is $0.00. Accelerated Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.25. Hence, Accelerated Pharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Accelerated Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

ACCP's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 17.76
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Accelerated Pharma's Cash Flow from Operations per share for the three months ended in Mar. 2017 was $-0.04. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.25.

Accelerated Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Accelerated Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Price-to-Operating-Cash-Flow Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Price-to-Operating-Cash-Flow

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Accelerated Pharma's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Accelerated Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerated Pharma's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accelerated Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Accelerated Pharma's Price-to-Operating-Cash-Flow falls into.

Accelerated Pharma Price-to-Operating-Cash-Flow Calculation

Accelerated Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.00	/	-0.251
	=

Accelerated Pharma's Share Price of today is $0.00.
Accelerated Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.25.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Accelerated Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines